CALL/MERCK & CO./180/0.1/20.09.24 | Real-time BOERSE MUENCHEN 10:26:32 2024-05-17 EDT | ||
| 0.01 EUR | -9.09% |
|
| Current month | -15.38% | ||
| 1 month | -15.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 0.01 | -9.09% |
| 24-05-16 | 0.011 | 0.00% |
| 24-05-15 | 0.011 | +37.50% |
| 24-05-14 | 0.008 | -20.00% |
| 24-05-13 | 0.01 | -9.09% |
Real-time BOERSE MUENCHEN
Last update May 17, 2024 at 10:26 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG1XEX |
| ISIN | DE000GG1XEX9 |
| Date issued | 2024-01-05 |
| Strike | 180 $ |
| Maturity | 2024-09-20 (126 Days) |
| Parity | 10 : 1 |
| Emission price | 0.01 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.029 € |
|---|---|
| Lowest since issue | 0.005 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.9
USD
Average target price
141.6
USD
Spread / Average Target
+8.22%
- Stock Market
- Warrants
- Warrant
